Literature DB >> 31316734

Changes in trend of cerebral venous sinus thrombosis.

Banafsheh Shakibajahromi1, Nahid Ashjazadeh1, Anahid Safari2, Afshin Borhani-Haghighi1.   

Abstract

Entities:  

Keywords:  Cerebral Veins; Patient Outcome Assessment; Sinus Thrombosis; Trends; Venous Thrombosis

Year:  2019        PMID: 31316734      PMCID: PMC6626603     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


× No keyword cloud information.
Although cerebral venous sinus thrombosis (CVST) is less common than arterial stroke, it affects younger patients.[1] Few studies have been performed to show the trend of CVST outcome over time.[2] We aimed to assess the trend of CVST epidemiology and its outcome in Namazee hospital, Shiraz, Iran. This is a high volume referral center for cerebrovascular diseases in southern Iran. Two retrospective studies were conducted on adult patients with definite diagnosis of CVST in two periods of time, 2000-2008[3] and 2012-2016.[4] We compared the demographic characteristics, risk factors and the outcome at the time of discharge between these two time periods. We applied Stata software (version 11, StataCorp LLC., College Station, TX, USA) for statistical analysis. Table 1 summarizes the results of comparison of CVST characteristics between the two time periods.
Table 1

Comparison of CVST characteristics between time periods 2000-2008 and 2012-2016

Variables
2000-2008 (n = 124)
2012-2016 (n = 174)
P
Demographic factors
Mean ± SD
Mean ± SD
Age (year)
34.01 ± 10.25
37.8 ± 11.2
0.003
n (%) n (%)
Women 87 (70.2)128 (73.6)0.518
Risk Factors
      Female Related Causes*67 (77.0)96 (75.0)0.691
      OCP*57 (65.5)73 (57.0)0.139
      Pregnancy/ Post-partum*10 (11.5)23 (18.0)0.124
      Inflammatory/Rheumatologic diseases13 (10.5)5 (2.9)0.007
      Infection11 (8.9)14 (8.1)0.806
      Thrombophilia9 (7.2)42 (24.3)< 0.001
      Other (Trauma, Malignancy, …)12 (9.7)15 (8.6)0.744
      Idiopathic16 (12.9)27 (15.6)0.514
Outcome
      Hospital mortality18 (14.5)9 (5.2)0.006
      Morbidity (mRS: 3-5) 44 (35.5)30 (17.2)< 0.001
      Recurrent Thrombosis12 (9.7)11 (6.3)0.278

SD: Standard deviation; CVST: Cerebral venous sinus thrombosis; OCP: Oral contraceptive pills; mRS: Modified Rankin Scale

Percent is calculated among the women.

Comparison of CVST characteristics between time periods 2000-2008 and 2012-2016 SD: Standard deviation; CVST: Cerebral venous sinus thrombosis; OCP: Oral contraceptive pills; mRS: Modified Rankin Scale Percent is calculated among the women. Morbidity and mortality of CVST in our region have diminished dramatically. This is most probably because of the advances in imaging techniques, which lead to more accurate and rapid diagnosis of CVST. Admission of patients with CVST in stroke units may also contribute to the decreased morbidity and mortality. Furthermore, better education of patients who are in risk of thrombosis about the possibility of developing CVST and its alarming symptoms in the recent years, has resulted in earlier admission of patients. Female gender-related causes are still the most frequent risk factors. It is common that Iranian women misuse oral contraceptive pills (OCP) in order to delay their menstruation during religious ceremonies such as Haj and fasting month of Ramadan.[5],[6] Although not significant, OCP use has declined among our patients with CVST. The increasing frequency of thrombophilia can be attributed to more complete diagnostic work-ups in the recent years. The decrease in frequency of inflammatory diseases cannot be explained.
  1 in total

1.  The Hospitalization Rate of Cerebral Venous Sinus Thrombosis before and during COVID-19 Pandemic Era: A Single-Center Retrospective Cohort Study.

Authors:  Maryam Vasaghi Gharamaleki; Maryam Habibagahi; Etrat Hooshmandi; Reza Tabrizi; Shahram Arsang-Jang; Zohreh Barzegar; Nima Fadakar; Vahid Reza Ostovan; Abbas Rahimi-Jaberi; Nahid Ashjazadeh; Peyman Petramfar; Maryam Poursadeghfard; Sadegh Izadi; Masoumeh Nazeri; Hanieh Bazrafshan; Zahra Bahrami; Sedigheh Karimlu; Seyedeh Shaghayegh Zafarmand; Mahnaz Bayat; Mohammad Saied Salehi; Maryam Owjfard; Saeideh Karimi-Haghighi; Anahid Safari; Banafsheh Shakibajahromi; Beng Lim Alvin Chew; Bradford B G Worral; Jonathan M Coutinho; Carlos Garcia-Esperon; Neil Spratt; Christopher Levi; Mahmoud Reza Azarpazhooh; Afshin Borhani-Haghighi
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-03-25       Impact factor: 2.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.